Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer.
Brodowicz T, Kostler WJ, Möslinger R, Tomek S, Vaclavik I, Herscovici V, Wiltschke C, Steger GG, Wein W, Seifert M, Kubista E, Zielinski CC.
Brodowicz T, et al. Among authors: steger gg.
Breast. 2000 Dec;9(6):338-42. doi: 10.1054/brst.2000.0170.
Breast. 2000.
PMID: 14965758